ESR1 and breast cancer: The degradation of ER and PgR has been shown to be under the control of the ubiquitin proteasome system [35,36,37,38,39], and recent research revealed that the phosphorylation of ERα via p38 activation promotes ERα turnover in breast cancer cells [40].